Related Experiment Video
Updated: Feb 17, 2026

12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
3.2K
Tailoring Liver Transplant Decisions: How Donor-Recipient Age Matching Influences Outcomes.
Abiha Abdullah1, Berkay Demirors1, Francis Spitz1
1Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Clinical Transplantation
|February 15, 2026
Summary
Donor age significantly impacts liver transplant (LT) success, with specific age thresholds identified for different recipient age groups. Older donors (≥50 years) pose higher risks, especially for pediatric liver transplant recipients.
Area of Science:
- Transplantation research
- Organ transplantation outcomes
- Geriatric medicine in transplantation
Background:
- Donor age is a critical factor influencing liver transplant (LT) success.
- The precise impact of donor age varies significantly across different recipient age demographics.
- Specific donor age thresholds linked to increased post-transplant risk are not well-defined.
Purpose of the Study:
- To define recipient age-specific donor age thresholds associated with adverse post-liver transplant outcomes.
- To identify critical donor age cutoffs that increase mortality and graft loss risk within distinct recipient age strata.
- To inform organ allocation strategies by quantifying donor age risks relative to recipient age.
Main Methods:
- Analysis of first-time, single-organ liver transplant (LT) recipients from the Scientific Registry of Transplant Recipients (2011-2021).
- Stratification of donors and recipients by age groups to assess outcomes.
- Multivariable Cox regression models were employed to identify donor age thresholds associated with increased risk, adjusting for key covariates.
Main Results:
- Donor age ≥50 years significantly increased mortality risk (aHR, 6.48) in pediatric liver transplant recipients.
- For adult recipients aged 18.1-30 years, donors >55 years were linked to excess mortality and graft loss (aHRs >2.5).
- Risk escalated with increasing donor age in recipients aged 40.1-60 years, while donor age showed no significant outcome association in recipients ≥65 years.
Conclusions:
- This study establishes recipient age-specific donor age thresholds for post-liver transplant risk, a novel national finding.
- The identified thresholds support the creation of age-informed organ allocation policies.
- Reevaluation of organ discard practices is recommended given the rising ages of both donors and recipients in liver transplantation.
Keywords:
death‐censored graft survivaldonor agegraft survivalliver transplantationrecipient agesurvivalMore Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
514
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
514
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Bone Marrow Sampling and Transplants
1.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.5K
Kidney Transplant II: Surgical Procedure
462
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
462

